Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis

The aim of this study was to analyze relationships between receptor activator of nuclear factor kappa-B (RANKL), sclerostin and their gene polymorphisms with radiological progression in patients with early rheumatoid arthritis (RA). Patients with early RA (n = 407, symptomatic <1 year) (ARA crite...

Descripción completa

Detalles Bibliográficos
Autores principales: Boman, Antonia, Kokkonen, Heidi, Ärlestig, Lisbeth, Berglin, Ewa, Rantapää-Dahlqvist, Solbritt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400786/
https://www.ncbi.nlm.nih.gov/pubmed/28190118
http://dx.doi.org/10.1007/s10067-017-3570-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400786/
https://www.ncbi.nlm.nih.gov/pubmed/28190118
http://dx.doi.org/10.1007/s10067-017-3570-4

Ejemplares similares